Clear Scientific Gains FDA Fast Track for CS-1103
CAMBRIDGE, Mass., May 6, 2026 Clear Scientific Inc., a clinical-stage biopharmaceutical company developing innovative therapies for acute drug intoxication,...
drug development
Advertisement
CARBOGEN AMCIS Passes Unannounced NMPA GMP Audit
BUBENDORF, Switzerland, May 6, 2026 CARBOGEN AMCIS, a global pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company,...
Nona Biosciences Appoints Josh Xiao as New CSO
CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...
Bayer to Acquire Perfuse Therapeutics in $2.45B Deal
BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...
Atossa Gains FDA RPD Status for Z-Endoxifen in MAS
SEATTLE, WASHINGTON, May 04, 2026 Atossa Therapeutics has announced that the U.S. Food and Drug Administration (FDA) has granted...
Advertisements
BioCryst, Neopharmed Sign $345M Europe HAE Deal
RESEARCH TRIANGLE PARK, NORTH CAROLINA, May 04, 2026 BioCryst Pharmaceuticals has announced a strategic European licensing agreement with an...
Merck Enpatoran Enters Phase 3 Trial for Lupus Treatment
Darmstadt, Germany | April 30, 2026 Merck has announced the first patient dosing in its global Phase 3 ELOWEN...
MapLight Therapeutics Completes Phase 2 CNS Trials Enrollment
SAN FRANCISCO & BOSTON, May 1, 2026 MapLight Therapeutics, Inc. announced the completion of enrollment in its Phase 2...
Iterative Health Secures $77M to Accelerate Clinical Trials
CAMBRIDGE, Massachusetts, April 2026 Iterative Health announced the successful close of a $77 million Series C funding round, reinforcing...
Cocrystal Pharma Advances CDI-988 for Norovirus Care
BOTHELL, Wash., April 30, 2026 Cocrystal Pharma, Inc., a clinical-stage biotechnology company focused on antiviral therapeutics, has presented new...
Advertisement
